Somewhat Positive Media Coverage Somewhat Unlikely to Affect Simulations Plus (SLP) Share Price
News articles about Simulations Plus (NASDAQ:SLP) have been trending somewhat positive this week, Accern Sentiment reports. Accern identifies positive and negative news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Simulations Plus earned a media sentiment score of 0.07 on Accern’s scale. Accern also assigned news headlines about the technology company an impact score of 45.91890060165 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Here are some of the headlines that may have effected Accern Sentiment’s rankings:
- ETFs with exposure to Simulations Plus, Inc. : December 15, 2017 (finance.yahoo.com)
- Reviewing NantHealth (NH) and Simulations Plus (SLP) (americanbankingnews.com)
- Simulations Plus (SLP) Cut to “Sell” at Zacks Investment Research (americanbankingnews.com)
- Does Zero-Debt Make Simulations Plus Inc (undefined:SLP) A Financially Strong Company? (finance.yahoo.com)
Simulations Plus (NASDAQ:SLP) opened at $16.55 on Tuesday. Simulations Plus has a one year low of $8.81 and a one year high of $17.45. The stock has a market cap of $284.33, a P/E ratio of 48.38 and a beta of -0.76.
The company also recently announced a quarterly dividend, which was paid on Monday, November 20th. Stockholders of record on Monday, November 13th were paid a $0.06 dividend. The ex-dividend date of this dividend was Friday, November 10th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 1.45%. This is a boost from Simulations Plus’s previous quarterly dividend of $0.05. Simulations Plus’s payout ratio is 72.73%.
A number of research firms have recently issued reports on SLP. BidaskClub cut shares of Simulations Plus from a “buy” rating to a “hold” rating in a research note on Wednesday, November 1st. Zacks Investment Research cut shares of Simulations Plus from a “buy” rating to a “hold” rating in a research note on Wednesday, September 20th.
In other news, insider Walter S. Woltosz sold 18,500 shares of Simulations Plus stock in a transaction that occurred on Saturday, October 28th. The shares were sold at an average price of $16.37, for a total value of $302,845.00. Following the completion of the transaction, the insider now owns 5,629,416 shares in the company, valued at $92,153,539.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders sold 55,500 shares of company stock valued at $880,600 in the last quarter. 36.93% of the stock is currently owned by corporate insiders.
ILLEGAL ACTIVITY NOTICE: This piece of content was first published by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/somewhat-positive-media-coverage-somewhat-unlikely-to-affect-simulations-plus-slp-share-price/1772918.html.
Simulations Plus Company Profile
Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.